Article citationsMore>>

Van Oosterom, A.T., Judson, I., Verweij, J., Stroobants, S., Donato di Paola, E., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., Silberman, S. and Nielsen, O.S. (2001) European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Safety and Efficacy of Imatinib (STI571) in Metastatic Gastrointestinal Stromal Tumours: A Phase I Study. The Lancet, 358, 1421-1423.

has been cited by the following article:

• TITLE: Gastrointestinal Stromal Tumor Mimicking Ovarian Tumor

  AUTHORS: Priyanka Kadam, Pariseema S. Dave, Meeta H. Mankad

  KEYWORDS: Gastrointestinal Stromal Tumor

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.5 No.11, September 16, 2015

  ABSTRACT: Background: Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors that may mimic ovarian tumor on presurgical testing. They are most often located in the stomach and proximal small intestine. The gross appearance of GISTs is highly variable. These tumors are usually asymptomatic, often discovered accidentally during endoscopic or radiologic examinations. Case Report: We reported a case of 55-year-old post menopausal woman who presented to us as ovarian mass which turned out to be malignant epithelioid gastrointestinal stromal tumor intraoperatively and by immunohistochemistry. Conclusion: In the patients with a pelvic mass, especially if unusual symptoms and laboratory data being not compatible with gynecological disease, the possibility of diseases other than a gynecologic disease has to be considered. Considering that only few patients with gastrointestinal stromal tumors have been reported in the obstetrical and gynecological literature, the awareness of such an entity by the obstetricians-gynecologists is necessary in order to facilitate coordinated approach with the general surgeons and oncologists for the optimal care of the patients.